Novartis AG (NVS)

88.12 +0.32  +0.36% NYSE Jul 8, 20:00 Delayed 2m USD

Novartis PS Ratio:

4.072 for July 8, 2020
View 4,000+ financial data types
Browse...
View Full Chart

PS Ratio Chart

Export Data
Save Image
Print Image

Historical PS Ratio Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
July 8, 2020 4.072
July 7, 2020 4.057
July 6, 2020 4.088
July 2, 2020 4.047
July 1, 2020 4.060
June 30, 2020 4.036
June 29, 2020 4.036
June 26, 2020 4.025
June 25, 2020 4.140
June 24, 2020 4.103
June 23, 2020 4.180
June 22, 2020 4.188
June 19, 2020 4.210
June 18, 2020 4.143
June 17, 2020 4.135
June 16, 2020 4.009
June 15, 2020 3.935
June 12, 2020 3.898
June 11, 2020 3.900
June 10, 2020 4.066
June 9, 2020 4.086
June 8, 2020 3.959
June 5, 2020 3.969
June 4, 2020 3.933
June 3, 2020 3.960
   
June 2, 2020 3.995
June 1, 2020 4.006
May 29, 2020 4.040
May 28, 2020 3.987
May 27, 2020 3.902
May 26, 2020 3.930
May 22, 2020 3.924
May 21, 2020 3.927
May 20, 2020 3.972
May 19, 2020 3.938
May 18, 2020 3.921
May 15, 2020 3.882
May 14, 2020 3.883
May 13, 2020 3.937
May 12, 2020 3.935
May 11, 2020 4.001
May 8, 2020 3.925
May 7, 2020 3.913
May 6, 2020 3.944
May 5, 2020 3.916
May 4, 2020 3.882
May 1, 2020 3.854
April 30, 2020 3.915
April 29, 2020 3.961
April 28, 2020 4.068

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Benchmarks

Benchmarks
AstraZeneca PLC 5.634
Gilead Sciences Inc 4.234
Johnson & Johnson 4.635

PS Ratio Range, Past 5 Years

Minimum 3.275 Dec 08 2016
Maximum 5.288 Nov 30 2018
Average 4.164
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.